✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Charles River Laboratories International Inc

Common Name
Charles River Laboratories
Country
United States
Sector
Healthcare
Industry
Diagnostics & Research
Employees
18,300
Ticker
CRL
Exchange
New York Stock Exchange
Description
Charles River Laboratories International, Inc. is a leading provider of essential products and services that support pharmaceutical, biotechnology, and medical device companies in drug discovery, deve...

Charles River Laboratories's Financial Statements Preview

Below are the financial statements of Charles River Laboratories, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Service revenue
3,304.14a
3,440.02a
3,216.9a
Product revenue
745.85a
689.39a
759.16a
Total revenue
4,049.99a
4,129.41a
3,976.06a
Costs and expenses
Cost of services provided (excluding amortization of intangible assets)
-2,345.78a
-2,295.98a
-2,143.32a
Cost of products sold (excluding amortization of intangible assets)
-372.39a
-330.87a
-370.09a
Selling, general and administrative
-751a
-747.86a
-665.1a
Amortization of intangible assets
-138.47a
-137.44a
-146.58a
Goodwill impairment
-215a
0a
0a
Operating income
227.35a
617.26a
650.98a
Other income (expense)
Interest income
8.58a
5.2a
0.78a
Interest expense
-126.29a
-136.71a
-59.29a
Other income (expense), net
-16.52a
95.54a
30.52a
Income before income taxes
93.11a
581.28a
622.99a
Provision for income taxes
-67.82a
-100.91a
-130.38a
Net income
25.29a
480.37a
492.61a
Less: Net income attributable to noncontrolling interests
3.09a
5.75a
6.38a
Net income attributable to Charles River Laboratories International Inc.
22.2a
474.62a
486.23a
Calculation of net income per share attributable to Charles River Laboratories International Inc. common shareholders
Net income attributable to Charles River Laboratories International Inc.
22.2a
474.62a
486.23a
Less: Incremental dividends attributed to noncontrolling interest holders
11.91a
0a
0a
Net income available to Charles River Laboratories International Inc. common shareholders
10.3a
474.62a
486.23a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Charles River Laboratories’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Charles River Laboratories's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?